logo
book Subscribe to our Magazine
    • Magazine
    • Membership
    • Donate
  • Racial Justice
  • Economic Justice
  • Climate Justice
  • Health Justice
  • Leadership
    • Grassroots Fundraising Journal
  • CONTENT TYPES
  • Podcasts
    • Tiny Spark
    • Women of Color in Power
  • Webinars
    • Free Webinars
    • Premium On-Demand Webinars
  • Membership

Shenanigans of Corporate Grantmaking

Rick Cohen
January 31, 2008
Share
Tweet
Share
Email
Print

It still takes the equivalent of Sam Spade to track corporate philanthropy, since so much of it occurs as “direct” corporate giving rather than publicly disclosed grantmaking through corporate foundations that have to file 990PFs. The nonprofit sector is still gunshy about asking corporate America for full corporate disclosure, despite lots of evidence of lots of perfidy in the purported charitiable activities of corporate scions. The latest revelations about corporate philanthropy come from Senators Baucus and Grassley at the Senate Finance Committee. Their 106-page report published in April 2007, charges “that drug companies were using educational grants for improper purposes, such as rewarding physicians for prescribing their drugs, influencing clinical practice guidelines and Medicaid formularies, or promoting drugs for uses that have not been approved by the FDA.” One particularly disturbing example involved Warner-Lambert (now Pfizer) “using educational grants to fund purportedly independent educational programs that actually served to promote the anti-epilepsy drug Neurontin” for so-called “off-label uses.” Company whistleblowers contacted the Departments of Justice and Health and Human Services who pursued the company for violations of federal law; Warner-Lambert ultimately paid $430 million to settle the claims.

The Committee’s 2007 report follows earlier findings released by the Committee when it was under Grassley’s leadership. The earlier report cited $1.47 billion in educational grants from 23 drug-makers in 2004, a 20 percent increase over 2003. Among the disturbing cases of that report was Johnson & Johnson having been the sole funder—to the tune of $1.3 million in grants between 1996 and 1999—to a purportedly independent patient advocacy group whose advocacy agenda was to promote the off-label use of Propulsid, a drug to treat heartburn in adults, for off-label use by children. When research linked Propulsid with dangerous heart arrhythmias in children, the toxic drug was withdrawn from the market and the supposedly independent patient advocacy group disappeared. In wonderful understatement, Senator Grassley observed that “It’s hard to see how you could call some of these grants ‘educational.’”

Sign up for our free newsletter

Subscribe to the NPQ newsletter to have our top stories delivered directly to your inbox.

By signing up, you agree to our privacy policy and terms of use, and to receive messages from NPQ and our partners.

Perhaps the Senate Finance Committee might have cause for a bit more concern if the members saw some of the latest figures on foundation giving and the role of the pharmaceuticals. A big and increasing chunk of corporate grantmaking comes from the pharmaceutical industry. In 2005, a dozen pharmaceutical foundations accounted for over $3 billion in donations of medications to people in need. Four of these pharmaceutical foundations now rank in the top 10 largest grantmaking foundations in the U.S., including philanthropic arms of Bristol-Meyers Squibb, Merck, GlaxoSmithKline, and Jansen Ortho. Expand to the top 50 in 2004 and you capture Roche, Lilly Cares, Boehringer Ingelheim Cares, and Aventis Pharmaceuticals. Some critics might suggest that the high prices of prescription drugs makes corporations’ charitable deductions for in-kind donations a somewhat dubious form of philanthropy. It all vaguely unsettling and worth a little scrutiny by both Congressional chambers.

Share
Tweet
Share
Email
Print
ABOUT THE AUTHOR
Rick Cohen

Rick joined NPQ in 2006, after almost eight years as the executive director of the National Committee for Responsive Philanthropy (NCRP). Before that he played various roles as a community worker and advisor to others doing community work. He also worked in government. Cohen pursued investigative and analytical articles, advocated for increased philanthropic giving and access for disenfranchised constituencies, and promoted increased philanthropic and nonprofit accountability.

More about: OpinionPhilanthropyThe Cohen Report

Become a member

Support independent journalism and knowledge creation for civil society. Become a member of Nonprofit Quarterly.

Members receive unlimited access to our archived and upcoming digital content. NPQ is the leading journal in the nonprofit sector written by social change experts. Gain access to our exclusive library of online courses led by thought leaders and educators providing contextualized information to help nonprofit practitioners make sense of changing conditions and improve infra-structure in their organizations.

Join Today
logo logo logo logo logo
See comments

NPQ_Spring_2022

You might also like
What Is the Nonprofit Sector of a Future, Equitable World?
Devon Kearney
New Data Tells Us Where Donor-Advised Fund Dollars Go—And Don’t Go
Chuck Collins and Helen Flannery
Report Maps the Philanthropy of Millionaire Donors of Color
Steve Dubb
One Nation Under a Groove: How to Build a Black Future Through Strong, Black-Led Community Organizations
Shawn A. Ginwright
This is What Solidarity Looks Like: Global Racial Justice in Antiwar Organizing
Kitana Ananda
Making Federal Infrastructure Funding Equitable—What Philanthropy Can Do
Lois DeBacker and Joe Evans

Upcoming Webinars

Group Created with Sketch.
June 9th, 2 pm ET

Remaking the Economy

Wage Justice, Now!

Register
You might also like
What Is the Nonprofit Sector of a Future, Equitable World?
Devon Kearney
New Data Tells Us Where Donor-Advised Fund Dollars Go—And...
Chuck Collins and Helen Flannery
Report Maps the Philanthropy of Millionaire Donors of Color
Steve Dubb
WOMEN OF COLOR IN POWER
Women of Color in Power

Listen wherever you get your podcasts.

Subscribe
Rep. Ayanna Pressley and Authentic Leadership
Reclaiming Interrupted Lineages

Like what you see?

Subscribe to the NPQ newsletter to have our top stories delivered directly to your inbox.

By signing up, you agree to our privacy policy and terms of use, and to receive messages from NPQ and our partners.

Independent & in your mailbox.

Subscribe today and get a full year of NPQ for just $59.

subscribe
  • About
  • Contact
  • Submissions
  • Advertisers
  • Newsletters
  • Copyright

Subscribe to View Webinars

We are using cookies to give you the best experience on our website.

 

Non Profit News | Nonprofit Quarterly
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.